Neurosense Therapeutics Ltd 宣布,其针对阿尔茨海默病的候选药物Primec在二期概念验证研究中取得了积极的生物标志物发现。这一进展为评估该疗法的潜在疗效提供了关键的科学依据。
Neurosense Therapeutics Ltd 宣布,其针对阿尔茨海默病的候选药物Primec在二期概念验证研究中取得了积极的生物标志物发现。这一进展为评估该疗法的潜在疗效提供了关键的科学依据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.